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Uveal melanoma (UM) is the most common primary 
intraocular malignancy, which is fatal in approximately 50% 
of patients because of untreatable diffuse metastases, which 
usually involve the liver. The risk of UM metastasis can be 
determined with a high degree of accuracy, when considering 
the clinical, histomorphological, and genetic features of these 
tumors during treatment [1]. The Liverpool Ocular Oncology 
Center (LOOC) is one of three referral centers for treating 
adult ocular tumors in England. Here, genetic prognostication 
testing for patients with UM is routinely performed, as part 
of the patient management protocol.
Choroidal melanoma (CM) represents the majority of 
UM involving the choroid and potentially the adjacent ciliary 
body but not the iris. Data were collected on patients with 
CM treated at the LOOC, including basic demographics, 
follow-up, and outcome and, since 2006, relative chromo-
some expression measurements across 43 chromosome sites 
(loci) representing four chromosomes (1p, 3, 6, and 8), using 
the technique known as multiplex ligation-dependent probe 
amplification (MLPA SALSA P027.B1, MRC, Holland [1]. 
Loci are identified on each chromosome corresponding to 
certain genes. The loci data themselves constitute relative 
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Purpose: To determine underlying correlations in multiplex ligation-dependent probe amplification (MLPA) data and 
their significance regarding survival following treatment of choroidal melanoma (CM).
Methods: MLPA data were available for 31 loci across four chromosomes (1p, 3, 6, and 8) in tumor material obtained 
from 602 patients with CM treated at the Liverpool Ocular Oncology Center (LOOC) between 1993 and 2012. Data 
representing chromosomes 3 and 8q were analyzed in depth since their association with CM patient survival is well-
known. Unsupervised k-means cluster analysis was performed to detect latent structure in the data set. Principal com-
ponent analysis (PCA) was also performed to determine the intrinsic dimensionality of the data. Survival analyses of 
the identified clusters were performed using Kaplan–Meier (KM) and log-rank statistical tests. Correlation with largest 
basal tumor diameter (LTD) was investigated.
Results: Chromosome 3: A two-cluster (bimodal) solution was found in chromosome 3, characterized by centroids 
at unilaterally normal probe values and unilateral deletion. There was a large, significant difference in the survival 
characteristics of the two clusters (log-rank, p<0.001; 5-year survival: 80% versus 40%). Both clusters had a broad 
distribution in LTD, although larger tumors were characteristically in the poorer outcome group (Mann–Whitney, 
p<0.001). Threshold values of 0.85 for deletion and 1.15 for gain optimized the classification of the clusters. PCA showed 
that the first principal component (PC1) contained more than 80% of the data set variance and all of the bimodality, with 
uniform coefficients (0.28±0.03). Chromosome 8q: No clusters were found in chromosome 8q. Using a conventional 
threshold-based definition of 8q gain, and in conjunction with the chromosome 3 clusters, three prognostic groups were 
identified: chromosomes 3 and 8q both normal, either chromosome 3 or 8q abnormal, and both chromosomes 3 and 
8q abnormal. KM analysis showed 5-year survival figures of approximately 97%, 80%, and 30% for these prognostic 
groups, respectively (log-rank, p<0.001). All MLPA probes within both chromosomes were significantly correlated with 
each other (Spearman, p<0.001).
Conclusions: Within chromosome 3, the strong correlation between the MLPA variables and the uniform coefficients 
from the PCA indicates a lack of evidence for a signature gene that might account for the bimodality we observed. We 
hypothesize that the two clusters we found correspond to binary underlying states of complete monosomy or disomy 3 
and that these states are sampled by the complete ensemble of probes. Consequently, we would expect a similar pattern 
to emerge in higher-resolution MLPA data sets. LTD may be a significant confounding factor. Considering chromosome 
8q, we found that chromosome 3 cluster membership and 8q gain as traditionally defined have an indistinguishable 
impact on patient outcome.
Correspondence to: Azzam Taktak, Department of Medical 
Physics and Clinical Engineering, Royal Liverpool University 
Hospital, Liverpool, L7 8XP, UK. Phone: +441517064202; FAX: 
+441517065803; email: afgt@liv.ac.uk
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measurements of the amount of target DNA present in the 
tumor biopsy tissue compared with a reference sample. These 
measurements are therefore unit-less: A normal result is close 
to unity, whereas low (e.g., <0.65) or high (e.g., >1.35) probe 
readings indicate loss or gain, respectively, at the corre-
sponding loci. These decision thresholds have been recom-
mended by the equipment manufacturer but are not neces-
sarily optimal. In particular, a reading of between 0.65 and 
0.85 is usually interpreted as borderline loss and 1.15–1.35 as 
borderline gain.
Non-random genetic changes may arise as partial or 
complete deletions (monosomy) or amplifications of chro-
mosomes (polysomy). There is convincing evidence that 
monosomy 3 and polysomy 8q are strongly associated with 
a poor survival prognosis in CM [2,3]. It would be useful 
to determine whether any of the MLPA loci predict clinical 
outcome in an individual patient and how the ensemble of 
MLPA data, itself a collection of continuous variables, is 
related to the categorical states of monosomy, disomy. or 
polysomy.
Comprehensive clinical, histomorphological, and genetic 
data exist for 602 patients with CM, but the high dimension-
ality of the data set means the data are sparse, and therefore 
relatively difficult to analyze with conventional statistical 
techniques. In this paper, we investigate the underlying struc-
ture of the data and correlation between MLPA variables, 
to reduce dimensionality and identify novel predictors of 
survival.
The main questions we addressed were as follows: What 
are the best thresholds in MLPA analysis for loss or gain? 
How are monosomy and polysomy best defined? Are there 
any special loci acting as “signature genes”? How well does 
MLPA analysis predict patient survival?
METHODS
Patients entered into this study included all those with CM 
who were treated at the Royal Liverpool University Hospital 
between 1993 and 2013. MLPA analysis came into routine 
use in 2006. However, this analysis included a few patients 
who were treated before 2006 and for whom tumor samples 
were available. Exclusion criteria were bilateral CM. Of the 
four chromosomes analyzed, the focus of this work was chro-
mosomes 3 and 8q, given their importance to CM patient 
survival. There were 13 loci within chromosome 3 and 4 loci 
in 8q (Table 1).
Data were analyzed using MATLAB® (The Mathworks 
Inc., Natick, MA) to determine the distribution of patients 
with CM within each locus. Within chromosome 3, the 13 loci 
measured for each patient were interpreted as 13 orthogonal 
spatial dimensions, and the 602 patients represented points 
situated within this 13-dimensional space. Three-dimensional 
Table 1. The measuremenT loci for chromosome 3p and 8q
Chromosomal Region Gene
3p25.3 FANCD2(i)
3p24.3 FANCD2(ii)
3p25.3 VHL
3p22.1 MLH1
3p22 CTNNB1
3p21.3 SEMA3B
3p14.2 FHIT(i)
3p14.2 FHIT(ii)
3p12.2 ROBO1
3q12 CPO
3q21.3 RHO
3q25.1 MME
3q29 OPA1
8q11.23 RP1
8q24.12 MYC(i)
8q24.12 MYC(ii)
8q24.2 DDEF1
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(3D) projections of the full data set were depicted given a 
choice of three specific loci.
Cluster analysis was used to identify latent structure 
in these data. Principal component analysis (PCA) was also 
performed to reduce the dimensionality of the data. The 
technique transformed the highly correlated combined input 
variables into a (potentially smaller) set of uncorrelated (and 
orthogonal) variables, which, when ordered, accounted for 
progressively smaller amounts of variance within the data. 
Geometrically, this amounted to rotating and translating the 
coordinate axes to align first with the direction of maximum 
spread (the first principal component), and then similarly for 
subsequent components, subject to the constraint of orthogo-
nality. Higher-order principal components exhibiting negli-
gible variance were discarded, and a projection of the data 
set was established that maximally exposed the structure/
variance already detected. A scree plot was used to determine 
the optimum number of principal components to describe the 
data.
Finally, chromosome data were correlated with the 
largest basal tumor diameter. Survival of any groups of 
patients identified by the clustering and PCA was determined 
with Kaplan–Meier curves and log-rank statistics using SPSS 
version 20 (IBM, NY).
This study adhered to the tenets of the Declaration of 
Helsinki. (Please note that there is no particular statement for 
ARVO on human subjects: it also refers to the Declaration of 
Helsinki. There is only a separate one for the “Use of Animals 
in Ophthalmic and Vision Research). The Institutional 
Table 2. clinicopaThologic feaTures of paTienTs included in The sTudy.
Feature n (%) Median (Range)
Sex Male Female
352 (58.5%) 
250 (41.5%)
Age, year 63.11 (15.75 – 94.4)
Largest basal tumour diameter, mm 14.3 (4.1 – 23.8)
Epithelioid 
cellularity Absent Present Unknown
231 (38.4%) 
341 (56.6%) 
30 (5%)
Anterior margin post-ora pre-ora
401 (66.6%) 
201 (33.4%)
Extra-ocular spread No Yes
525 (87.2%) 
77 (12.8%)
Ciliary body involvement No Yes Unknown
401 (66.7%) 
200 (33.2%) 
1 (0.1%)
TNM stage T1 T2 T3 T4 Unknown
96 (15.9%) 
159 (26.4%) 
224 (37.2%) 
119 (19.8%) 
4 (0.7%)
Treatment Brachytherapy Scleral 
resection Enucleation Proton beam 
therapy Endoresection Treated 
elsewhere Other
87 (14.4%) 
48 (8%) 
312 (51.8%) 
89 (14.8%) 
38 (6.3%) 
18 (3%) 
10 (1.7%)
Followup time, year 3.08 (0.07 – 19.7)
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Research Governance Board approved this study for service 
evaluation.
RESULTS
Cluster analysis: A summary of the demographics of the 
patients with CM is shown in Table 2. Initial projections 
suggested PCA showed that the data points for chromosome 
3 were distributed over a small range, typically between 0 
and 2–2.5. In each projection, the presence of two distinct 
clusters within the data was (subjectively) discerned: One 
shifted toward higher probe measurements, and the other 
approximated zero. These clusters were better separated 
in some projections than in others, but the presence of two 
regions of high density was clear. This was confirmed with 
simple histogram plots of selected loci, where bimodal distri-
butions were always observed.
The results of a two-means cluster analysis of the chromo-
some 3 data are shown in Appendix 1 and Appendix 2. These 
appendices show the 3D projections and the histograms, with 
the data classified into one or other of the clusters, indicated 
by the markers in different shades of gray. Since the output of 
this iterative algorithm depends (in principle) upon the initial, 
random allocation of data to the classes, the routine was 
executed five times, and on each occasion, the total distance 
to the centroids in the final iteration was calculated and found 
to be stable at 165.27. Stability of this parameter across trials 
suggests that a global minimum of convergence was found. 
These appendices show that the first cluster (C1) generally 
corresponds to lower MLPA measurements, with its centroid 
indicating deletions on all loci, whereas the second cluster 
(C2) has a centroid which indicates normal readings (close to 
unity) on all probes.
A plot of the silhouette scores for the two-cluster solu-
tion is given in Appendix 3, and the global mean silhouette 
score is plotted against the number of clusters. The silhouette 
score reached a maximum of 0.8 at two clusters, indicating 
this choice was appropriate. There was a large, significant 
difference in the survival characteristics of the two clusters 
(log-rank, p<0.001; 5-year survival: 80% versus 40%).
The 3D scatter plots in Appendix 1 show that in each 
projection the data are arrayed diagonally through the variable 
space, suggesting a degree of pair-wise correlation between 
variables. Robustly, a test for monotonic correlation between 
each pair of variables (13 ×12 / 2 = 78 possible combinations) 
showed strong evidence against the null hypothesis of zero 
correlation in every case with a Spearman coefficient that was 
always at least 0.62, and, excluding OPA1 (3q29), always at 
least 0.70 (p<0.001). Correlation seemed to be slightly weaker 
for many of the pairs involving the OPA1 probe (Table 3). 
An initial review of the four loci in chromosome 8q did 
not reveal any obvious multimodal features, unlike chromo-
some 3, although in each case there was a clear single peak 
at unity and a non-symmetric distribution skewed toward 
higher probe values. Similarly, a 3D scatter plot did not 
suggest any obviously distinct groups within the data, though 
some degree of correlation between the variables was seen. 
Calculating Spearman correlation coefficients between each 
pair of probes showed significant correlations between all 
combinations (p<0.001), and in particular between MYC(i) 
and MYC(ii); (8q24.12); where r=0.9255, (p<0.001; Table 
4). Spearman coefficients were characteristically smaller 
(0.23–0.25) for all pairs involving DDEF1 (8q24.2), compared 
with at least 0.58 for all other combinations.
Chromosome 3 deletion frequency: There is uncertainty about 
the prognostic significance of ambiguous MLPA results (e.g., 
if only three out of 13 loci on chromosome 3 were deleted). 
This was investigated by considering how the total number of 
deletions for each patient is distributed over the two clusters. 
In Appendix 4, the distribution of total number of deletions 
is indicated, stratified by cluster, for the two threshold values 
customarily used (i.e., 0.65 and 0.85). Using the 0.65 threshold 
(Appendix 4), the data are skewed toward no deletions at all, 
and although the majority of patients with no deletions are 
in cluster 2, several patients are in cluster 1 with no MLPA 
readings below 0.65, as indicated by the overlapping section 
at 0 deletions. Between one and three locus deletions, there 
is a fairly even split between the two clusters. This indicates 
that on this information alone it is very difficult to correctly 
classify a patient with a few or no deletions into one of these 
groups. Conversely, the weaker deletion threshold of 0.85 
(Appendix 4) seems to offer a much smaller intersection 
between the two clusters: There is now a more equal split of 
patients between no deletions and all deletions, and further-
more, all patients with ten or more deletions belong to cluster 
1, while patients with seven or fewer are in cluster 2. A small 
number of patients have eight or nine MLPA scores below 
0.85, and these are split between the two groups.
Principal component analysis: The required rotation matrix 
was calculated, after the data were centered by subtracting 
the respective mean value from each probe reading for chro-
mosome 3 [4]. A scree plot is given in Appendix 5 indicating 
the percentage of the total variance contained within the 
first seven principal components. Together these compo-
nents account for more than 95% of the variance, with the 
majority (78%) in the first component. Histograms showing 
the distributions of data in the first three components are also 
shown in Appendix 5 (no significant structure was observed 
in the distribution of subsequent component values, which 
Molecular Vision 2015; 21:1-11 <http://www.molvis.org/molvis/v21/1> © 2015 Molecular Vision 
5
Ta
b
l
e
 3
. s
pe
a
r
m
a
n
 c
o
r
r
e
l
a
T
io
n
 c
o
e
ff
ic
ie
n
T
s f
o
r
 T
h
e
 d
if
fe
r
e
n
T
 l
o
c
i i
n
 c
h
r
o
m
o
so
m
e 
3.
 a
l
l
 c
o
r
r
e
l
a
T
io
n
s w
e
r
e
 si
g
n
if
ic
a
n
T
 w
iT
h
 p
<0
.0
01
.
G
en
e
Sp
ea
rm
an
 r
FA
N
C
D
2(
ii)
V
H
L
M
L
H
1
C
T
N
N
B1
SE
M
A
3B
FH
IT
(i)
FH
IT
(ii
)
R
O
B
O
1
C
PO
R
H
O
M
M
E
O
PA
1
FA
N
C
D
2(
i)
0.
87
8
0.
84
8
0.
82
4
0.
79
1
0.
82
3
0.
78
0
0.
77
1
0.
74
8
0.
80
4
0.
78
6
0.
78
0
0.
68
7
FA
N
C
D
2(
ii
)
-
0.
87
1
0.
83
4
0.
78
1
0.
78
3
0.
85
2
0.
82
0
0.
74
3
0.
80
0
0.
77
8
0.
80
8
0.
67
6
V
H
L
-
-
0.
82
2
0.
70
1
0.
76
3
0.
74
9
0.
72
6
0.
70
5
0.
78
1
0.
74
3
0.
72
3
0.
62
0
M
LH
1
-
-
-
0.
70
4
0.
75
4
0.
81
0
0.
79
4
0.
71
7
0.
77
4
0.
76
8
0.
80
6
0.
62
9
C
T
N
N
B
1
-
-
-
-
0.
80
1
0.
79
4
0.
75
9
0.
84
7
0.
79
5
0.
72
2
0.
77
9
0.
69
8
SE
M
A
3B
-
-
-
-
-
0.
73
7
0.
70
8
0.
74
6
0.
75
3
0.
80
6
0.
73
7
0.
67
5
F
H
IT
(i
)
-
-
-
-
-
-
0.
83
6
0.
80
9
0.
81
6
0.
75
7
0.
86
2
0.
68
6
F
H
IT
(i
i)
-
-
-
-
-
-
-
0.
77
2
0.
77
0
0.
74
6
0.
84
3
0.
66
7
RO
B
O
1
-
-
-
-
-
-
-
-
0.
79
8
0.
74
7
0.
80
3
0.
64
2
C
PO
-
-
-
-
-
-
-
-
-
0.
76
9
0.
80
2
0.
67
3
R
H
O
-
-
-
-
-
-
-
-
-
-
0.
81
3
0.
63
2
M
M
E
-
-
-
-
-
-
-
-
-
-
-
0.
70
8
Molecular Vision 2015; 21:1-11 <http://www.molvis.org/molvis/v21/1> © 2015 Molecular Vision 
6
are not shown). Moreover, the bimodal distribution shown in 
Appendix 2 is now only seen in the first component, compared 
with the bimodal distributions observed along every axis of 
the untransformed variables, suggesting that the clusters are 
arrayed along some kind of diagonal in the 13-dimensional 
input space. The matrix coefficients for the first principal 
component were uniform (each fell within a small range of 
0.28±0.03). Thus, along the axis of the largest variance (in 
which the clusters are now seen to be exclusively separated), 
no probe in particular distinguishes between one cluster and 
the other; instead, an even mix of all probes appears to be 
relevant. A scatter plot of the data in the first two principal 
components is shown in Figure 1, with the data points shaded 
according to the original k-means classification. The power of 
the PCA technique is well demonstrated; having begun with a 
13-dimensional space impossible to fully visualize, it is now 
possible to separate these clusters by eye, placing a dividing 
vertical line somewhere near the origin.
PCA analyses were repeated for chromosome 8q. The 
results showed that nearly all of the variance was contained 
within the first three components, and more than 90% in the 
first two components. Coefficients for these components 
showed a small contribution by DDEF1 (8q24.2) in the first 
component, but a large contribution from this same probe 
in the second, which is consistent with the smaller correla-
tion between this variable and the other three. There was no 
obvious grouping of data in chromosome 8q as was seen with 
chromosome 3. Applying the k-means algorithm with a range 
of values of k suggested the presence of two clusters, with 
a mean silhouette score of 0.728, though there were several 
negative scores, and the visualization in principal component 
space was not convincing. Therefore, a threshold-based defi-
nition of 8q gain on which to base subsequent analysis was 
considered in conjunction with the results of the chromosome 
3 analysis. Figure 2 shows the joint space formed from the 
first principal components of chromosome 3 and chromosome 
Table 4. spearman correlaTion coefficienTs for The differenT loci in 
chromosome 8. all correlaTions were significanT wiTh p<0.001.
Gene
Spearman r
MYC(i) MYC(ii) DDEF1
RP1 0.583 0.609 0.240
MYC(i) - 0.926 0.241
MYC(ii) - - 0.253
Figure 1. Scatter plot of the 
(centered) chromosome 3 data in 
the first two principal components, 
with points colored according to the 
cluster. This represents an optimal 
two-dimensional projection of the 
data.
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8q. Patients with a gain in chromosome 8q (i.e. three or four 
probes taking a value >1.15) occurred equally in both chro-
mosome 3 groups and tended to predominantly occupy the 
upper half of this plot. This indicates the possibility of the 
presence of three clusters when the two chromosomes are 
combined.
Survival analysis: Based on these results, cases were classi-
fied as chromosome 3 deletion if they belonged to cluster C1 
or normal chromosome 3 if they belonged to cluster C2. Cases 
were further classified as chromosome 8q gain if the three or 
four probes took a value >1.15; otherwise, they were classified 
as normal for chromosome 8q. Jointly, cases were classified 
into four prognostic groups: (i) normal chromosomes 3 and 
8q; (ii) chromosome 3 deletion, normal chromosome 8q; (iii) 
normal chromosome 3, chromosome 8q gain; and (iv) chro-
mosome 3 deletion, chromosome 8q gain.
The Kaplan–Meier plots for these four groups are shown 
in Figure 3. The figure shows the individuals allocated to 
group (i) have the best outcomes, with a cumulative survival 
of 97% at 5 years (95% CI=94–99.6%). This is in contrast to 
those in group (iv), with 30.3% 5-year cumulative survival 
(95% CI=20.5–40.1%). There are two middle groups, with 
abnormal results on only one chromosome (3 or 8q, but not 
both). Log-rank statistics show that the difference between 
each pair of survival curves is statistically significant 
(p<0.001) apart from the middle two (p=0.341; Table 5). 
This result suggests that chromosome 3 deletion or chromo-
some 8q gain has an essentially indistinguishable impact on 
outcome, when it occurs in isolation.
A plot of the distribution of the largest basal tumor diam-
eter for the two clusters is given in Figure 4. A slight bias 
toward larger tumors is seen for cluster 1 (poorer outcomes), 
and smaller tumors for cluster 2 (better outcomes); however, 
there is a large overlap between the two distributions, indi-
cating a wide range of tumor diameters in both groups. A 
Mann–Whitney test for equality of medians showed strong 
evidence against the null hypothesis (p<0.001), and that there-
fore tumors are characteristically larger in the first cluster.
DISCUSSION
Main findings: This study shows that the MLPA chromosome 
3 measurements are arrayed in two well-defined clusters. 
This clustering solution was validated with a commonly 
used metric based on silhouette values. Kaplan–Meier 
analysis confirmed three prognostic groups: group 1 (normal 
chromosomes 3 and 8q), group 2 (either 3 or 8q abnormal), 
Figure 2. Representation of the data 
in the joint space formed from the 
first principal components of chro-
mosome 3 and chromosome 8q.
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and group 3 (3 and 8q abnormal). We also found that each 
of the 13 probes on chromosome 3 strongly correlates with 
all the others, although this correlation was weaker for the 
13th probe; the reason is unclear. The correlation in the data 
indicated a lower intrinsic dimensionality in the data set 
than suggested by the sheer number of loci sampled. Indeed, 
principal component analysis showed that through suitable 
transformation of coordinate axes, more than 95% of the 
variation in the data was contained within seven orthogonal 
components, and all the bimodal structure within the first 
principal component. Moreover, this first principal compo-
nent comprised a uniform mix of the 13 probes, suggesting 
there are no preferred loci accounting for the majority of 
variation in the data. The results also showed strong correla-
tion between the clusters and tumor size. Since tumor size is a 
strong predictor of survival, tumor size may be a confounding 
factor in inferring any causal link from the Kaplan–Meier 
analysis. Examining the distribution of tumor stages in the 
three groups shows that the majority of tumors at stage T1 
(57%) belong to group 1 whereas the majority of those at stage 
T4 (54%) are in group 4 (χ2, p<0.001). This suggests that the 
huge difference between the survival curves for these two 
groups can be at least partially attributed to lead time bias.
Chromosome 8q did not show any readily identifiable 
clustering pattern, although there was significant cross-corre-
lation between the probe measurements, particularly the two 
probes on 8q24.12. Further, PCA showed that nearly all of the 
variance in the data was confined to three orthogonal compo-
nents. Although there was no obvious clustering solution, the 
8q data could be classified in a more traditional manner based 
on the suggested gain threshold of 1.15.
Figure 3. Kaplan–Meier cumula-
tive survival functions for the four 
patient groups identified jointly 
using the k-means clustering solu-
tion (chromosome 3) and a simple 
thresholding condition on chro-
mosome 8q. Group 1 represents 
disomy 3 and disomy 8 (n=220), 
group 2 represents monosomy 3 
and disomy 8 (n=113), group 3 
represents disomy 3 and polysomy 
8 (n=104), and group 4 represents 
monosomy 3 and polysomy 8 
(n=165).
Table 5. pairwise log-rank sTaTisTical TesT (p values in brackeTs) for The four 
prognosTic groups; group 1 represenTs disomy3 and disomy8 (n=220), group 2 
represenTs monosomy3 and disomy8 (n=113), group 3 represenTs disomy3 and poly-
somy8 (n=104) and group 4 represenTs monosomy3 and polysomy8 (n=165).
Prog-
nostic Group
Log-rank statistic (p)
2 3 4
1 22.426  (< 0.001) 11.353 (0.001) 134.665 (< 0.001)
2 - 1.919 (0.341) 28.869 (< 0.001)
3 - - 46.93 (< 0.001)
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Strengths and weaknesses: The main strength of this study is 
the large sample size of 602 patients with a median follow-up 
time of more than 3 years. In this study, latent structure in 
the data was examined to classify the patients before survival 
of the different classes was examined. The main weakness 
is that the results must be validated with an unseen data 
set beyond the 602 patients. One potential difficulty is that 
new patient data are acquired using a new assay of 19 loci 
in chromosome 3 instead of 13, and not all of the original 
13 loci are still available. However, results presented in this 
study suggest that no preferred probe (or subset of probes) 
discriminates between the two prognostic groups identified 
in chromosome 3 but that all 13 probes are important as 
indicated by the first principal component. By increasing the 
number of probes, therefore, the sampling resolution of essen-
tially binary clustering is increased, and a similar clustering 
pattern into two groups is expected in the new data set.
Comparison with previous studies: Previous studies that 
relied on fluorescent in situ hybridization (FISH) for identi-
fying monosomy or disomy 3 showed significant differences 
in survival between the two classes [5-9]. Results from these 
studies showed that the technique had a high specificity but 
low sensitivity [10,11]. With MLPA analysis, chromosomal 
abnormalities can be detected on a larger number of loci 
and using a scalar measure rather than a binary measure. 
Figure 4. Distribution in LUD for 
each cluster. The Mann–Whitney 
test strongly indicates the medians 
are not equal.
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Therefore, there is potential for this technique to identify 
more prognostic groups using all the information from this 
analysis. In this study, we looked at the latent structure of 
the data to determine the possibility of the existence of more 
prognostic groups.
Clinical and research implications: There is scope for further 
research investigating whether a multinomial regression 
model or a Gaussian process can be fitted to this joint space, 
to predict probabilities of class membership in this three-
way partitioning of the data of the three prognostic groups 
identified. An anticipated challenge is the relative sparseness 
of the data. As a rule, ten to 20 data points in each class 
are required for each predictor. For multiple classes with 
potentially 17 predictors and only 602 patients in total, this 
becomes a limiting factor. It should be possible to extract a 
subspace of lower dimensionality from the joint space as has 
been attempted here for the two chromosomes in isolation.
Finally, despite the apparent existence of up to three 
prognostic groups in the joint space of chromosome 3 and 
chromosome 8q, a few patients cannot be classified on this 
basis. For example, 11 patients (1.8%) survived more than 5 
years, despite abnormal results for chromosomes 3 and 8q. 
We could not identify anything from the histopathology or 
available genetic information that might explain this disparity 
although nine of these 11 tumors had no extraocular spread. 
Additional variables might play a role in the survival of these 
patients such as psychological factors. A more focused study 
of these particular patients’ clinical and histopathological 
data is currently in progress.
Conclusion: This study shows that for MLPA data in 
CM, there is a strong suggestion of two groups of patients 
according to chromosome 3 data, and that this was confirmed 
with k-means clustering. A two-cluster solution was estab-
lished and validated. The center points of these two clusters 
correspond to 13 deletions (<0.65) and 13 normal probe 
readings (about 1.0). Survival analysis showed statistically 
significant differences between the two groups. However, 
the difference between the median tumor diameters in each 
cluster was also statistically significant, which is a possible 
source of a confounding error.
Clusters were well characterized by considering the 
total number of deletions, if the deletion threshold was taken 
as 0.85 instead of 0.65. Patients with ten or more deletions 
(<0.85) out of a possible 13 are exclusively in cluster 1 (poor 
prognosis) and seven or fewer in cluster 2 (good prognosis). 
A small number of patients have eight or nine deletions, and 
these are split between the two groups. There was a strong 
correlation between the probes so the data set does not fill 
out the full space made up of 13 probes but is restricted to 
a smaller variable space. PCA supplements this by demon-
strating that most of the variation in the chromosome 3 data 
was characterized by one new variable that is an even mix of 
all probes (equivalent to a mean probe value). The study was 
unable to identify a preferred probe or subset of probes that 
were exclusively abnormal in the poorer outcome cluster (i.e., 
no signature genes were detected). Instead, we hypothesized 
that the two groups of data we found correspond in some way 
to underlying binary states of complete monosomy or disomy 
3. The new measurement kit comprises 19 probes instead of 
13, with different chromosome loci. We therefore expect to 
see a similar two-cluster solution in the new data (i.e, we have 
essentially increased the sampling frequency).
For chromosome 8q, there was no obvious clustering 
as for chromosome 3. As with chromosome 3, each locus is 
correlated with every other locus. Using the current conven-
tion for chromosome 8q gain (three or four probes out of four 
are >1.15), and considering the joint space of chromosome 3 
and chromosome 8q, three significantly different prognostic 
groups were confirmed: both 3 and 8q normal, both 3 and 8q 
abnormal, and either 3 or 8q abnormal.
APPENDIX 1.
To access the data, click or select the words “Appendix 1.” 
Some examples of 3D projections with each point classified 
according to the output of the kmeans algorithm, for k=2. 
The clusters appear better defined in some projections than 
others, but the intuitive overall picture seems to have been 
well captured by the algorithm.
APPENDIX 2.
To access the data, click or select the words “Appendix 2.” 
Histograms with clusters binned separately. It can be seen 
that the two peaks in the bimodal distributions correspond 
distinctly to the K-means classification.
APPENDIX 3.
To access the data, click or select the words “Appendix 3.” (A) 
Silhouette scores plotted horizontally for the 602 data points 
when k=2, indicating the majority of points have a silhouette 
score in the range 0.6 - 0.9. (B) A plot of mean silhouette 
score against k, indicating the optimum clustering solution 
has been found at k=2.
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APPENDIX 4.
To access the data, click or select the words “Appendix 4.” 
Distribution of the data in total number of deletions, stratified 
by cluster, where a deletion has been defined as <0.65 (A) 
and <0.85 (B).
APPENDIX 5.
To access the data, click or select the words “Appendix 5.” 
Principal Component Analysis of chromosome 3 data. (A): 
Scree plot showing the distribution of variance (and ≥95% 
cumulative variance) over the first seven components. 
Nearly 80% of the total variance is contained within the first 
principle component. (B, C, D): Distribution of the data in 
the first three principle components, the bimodality is now 
exposed exclusively in the first component, and the variance 
reduces in successive components as the distributions become 
progressively narrower and taller (note the change in vertical 
scale for constant bin widths).
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